In vivo distribution of [11C]-busulfan incynomolgus monkey and in the brain of a human patient Moustapha HassanGunnar öbergLennart Widén Original Articles Pages: 81 - 85
Toxicity and metabolism of 3′-deoxyadenosine N1-oxide in mice and Ehrlich ascites tumor cells Karsten Ramløv SvendsenKay Overgaard-HansenLars Lindhardt Vindeløv Original Articles Pages: 86 - 94
Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529 Cristiana AgenNunzia BernardiniMario Del Tacca Original Articles Pages: 95 - 99
Ifosfamide, vincristine, doxorubicin and dacarbazine in adult patients with advanced soft-tissue sarcoma Tom A. WiklundCarl P. BlomqvistInkeri Elomaa Original Articles Pages: 100 - 104
Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations Jochem KöttingMartin R. BergerHansjörg Eibl Original Articles Pages: 105 - 112
Chemosensitivity of human MCF-7 breast cancer cells to diastereoisomeric diaqua(1,2-diphenylethylenediamine) platinum(II) sulfates and specific platinum accumulation Herta ReileGünther BernhardtFranz Lux Original Articles Pages: 113 - 122
Doxorubicin inhibits human DNA topoisomerase I P. David FoglesongCalvin ReckordSharon Swink Original Articles Pages: 123 - 125
Phenotypic analysis of 1-B-d-arabinofuranosylcytosine deamination in patients treated with high doses and correlation with response W. KreisM. LesserS. Akerman Original Articles Pages: 126 - 130
Activity of two platinum-linked phosphonic acids against autochthonous rat colorectal cancer as well as in two human colon-cancer cell lines A. GaleanoM. R. BergerB. K. Keppler Original Articles Pages: 131 - 138
The role of deoxycytidine-metabolizing enzymes in the cytotoxicity induced by 3′-amino-2′,3′-dideoxycytidine and cytosine arabinoside William R. Mancini Original Articles Pages: 139 - 144
Effect of a low-protein diet on doxorubicin pharmacokinetics in the rabbit Barry J. CusackStephan P. YoungRichard D. Olson Original Articles Pages: 145 - 148
Gut protection by cyclophosphamide “priming” in patients receiving high-dose melphalan — effect of drug scheduling Janine MansiElisabeth EllisDavid Cunningham Short Communication Pages: 149 - 151
Synergistic interaction of cyclosporin A and verapamil on vincristine and daunorubicin resistance in multidrug-resistant human leukemia cells in vitro Kathryn OsannPaula SweetLewis M. Slater Short Communication Pages: 152 - 154
A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemia Peter C. AdamsonSolomon ZimmDavid G. Poplack Short Communication Pages: 155 - 157
Bleomycin lung: the effect of different chemotherapeutic regimens R. A. ChisholmA. K. DixonR. T. D. Oliver Short Communication Pages: 158 - 160
Pilot study of escalating doses of carboplatin and cyclophosphamide in patients with advanced cancer Russell L. BasserMichael D. GreenRichard M. Fox Short Communication Pages: 161 - 163
Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier Yoshiaki TakadaNigel H. GreigQuentin R. Smith Erratum Pages: 164 - 164